JNK INHIBITION SENSITIZES HEPATOCELLULAR CARCINOMA CELLS BUT NOT NORMAL HEPATOCYTES TO TNF-RELATED APOPTOSIS INDUCING LIGAND, INHIBITS ANCHORAGE-INDEPENDENT GROWTH AND INVASION

被引：0

作者：

Mucha, Simon R. ^{[1
]}

Rizzani, Antonia ^{[1
]}

Sonuc, Niluefer ^{[1
]}

Schnabel, Uta ^{[1
]}

Thasler, Wolfgang ^{[2
]}

Gerbes, Alexander L. ^{[1
]}

Camaj, Peter ^{[2
]}

Diehl, Danielo ^{[3
]}

Lahm, Harald ^{[3
]}

Eichhorst, Soeren T. ^{[1
]}

Gallmeier, Eike ^{[1
]}

Bruns, Christiane ^{[2
]}

Goeke, Burkhard ^{[1
]}

Kolligs, Frank ^{[1
]}

De Toni, Enrico N. ^{[1
]}

机构：

[1] Univ Munich LMU, Dept Internal Med, Munich, Germany

[2] Univ Munich LMU, Dept Surg, Munich, Germany

[3] Univ Munich LMU, Dept Anim Breeding, Munich, Germany

来源：

HEPATOLOGY | 2008年 / 48卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1532

引用

页码：987A / 987A

页数：1

共 42 条

[21] Inhibition of ATF5 Sensitizes Glioblastoma Cells to the Cytotoxic Effects of TNF-Related Apoptosis Inducing-Ligand (TRAIL) in a CHOP-DR5 Dependent Manner [J].

Siegelin, M. D. ;

Angelastro, J. M. ;

Greene, L. A. .

MODERN PATHOLOGY, 2013, 26 :418A-418A

[22] Inhibition of ATF5 Sensitizes Glioblastoma Cells to the Cytotoxic Effects of TNF-Related Apoptosis Inducing-Ligand (TRAIL) in a CHOP-DR5 Dependent Manner [J].

Siegelin, M. D. ;

Angelastro, J. M. ;

Greene, L. A. .

LABORATORY INVESTIGATION, 2013, 93 :418A-418A

[23] TNF-related apoptosis-inducing ligand (TRAIL) inhibits primary bone tumor growth and augments survival in a human model Ewing sarcoma [J].

Geffroy, Loic ;

Chauviere, Damien ;

Lamoureux, Francois ;

Picarda, Gaelle ;

Burchill, Susan ;

Delattre, Olivier ;

Delepine, Pascal ;

Gouin, Francois ;

Heymann, Dominique ;

Redini, Francoise .

CANCER TREATMENT REVIEWS, 2008, 34 :S72-S72

[24] INHIBITION OF ANCHORAGE-INDEPENDENT GROWTH OF RAT HEPATOCELLULAR-CARCINOMA CELLS MH1C1 BY DL-METHIONINE [J].

BRADA, Z ;

HILL, M ;

HILLOVA, J .

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 :28-28

[25] Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up-regulation of TNF-related apoptosis-inducing ligand [J].

Wang, Lingyan ;

Min, Zhihui ;

Wang, Xiangdong ;

Hu, Mushuang ;

Song, Dongli ;

Ren, Zhenggang ;

Cheng, Yunfeng ;

Wang, Yanhong .

ONCOLOGY LETTERS, 2018, 16 (03) :3341-3350

[26] Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL) [J].

Rychahou, PG ;

Murillo, CA ;

Evers, BM .

SURGERY, 2005, 138 (02) :391-397

[27] Chelerythrin overcomes resistance to TRAIL (TNF-related apoptosis inducing ligand) in KG1a cells but not in normal CD34+precursors. [J].

Platzbecker, U ;

Deeg, HJ .

BLOOD, 2002, 100 (11) :543A-543A

[28] The induction of apoptosis by histone deacetylase inhibition in chronic lymphocytic leukemia (CLL) cells is mediated through the TNF-related apoptosis-inducing ligand (TRAIL) pathway. [J].

Szwajcer, D ;

Gibson, SB ;

Johnston, JB .

BLOOD, 2005, 106 (11) :836A-836A

[29] Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C [J].

Tillman, DM ;

Izeradjene, K ;

Szucs, KS ;

Douglas, L ;

Houghton, JA .

CANCER RESEARCH, 2003, 63 (16) :5118-5125

[30] Second mitochondrial-derived activator of caspases (SMAC) mimetic LCL-161 and TNF-related apoptosis-inducing ligand (TRAIL) induce apoptosis through a kinase-independent RIP1 function in sensitive breast cancer cells [J].

Holmgren, Christian ;

Thornberg, Ellen Sunstrom ;

Granqvist, Victoria ;

Larsson, Christer .

CELL DEATH DISCOVERY, 2019, 5

← 1 2 3 4 5 →